These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7881097

  • 1. Modulation of breast cancer progression and differentiation by the gp30/heregulin [correction of neregulin].
    Staebler A, Sommers C, Mueller SC, Byers S, Thompson EW, Lupu R.
    Breast Cancer Res Treat; 1994; 31(2-3):175-82. PubMed ID: 7881097
    [Abstract] [Full Text] [Related]

  • 2. The significance of heregulin in breast cancer tumor progression and drug resistance.
    Lupu R, Cardillo M, Cho C, Harris L, Hijazi M, Perez C, Rosenberg K, Yang D, Tang C.
    Breast Cancer Res Treat; 1996; 38(1):57-66. PubMed ID: 8825123
    [Abstract] [Full Text] [Related]

  • 3. William L. McGuire Memorial Symposium. The role of erbB2 signal transduction pathways in human breast cancer.
    Lupu R, Lippman ME.
    Breast Cancer Res Treat; 1993; 27(1-2):83-93. PubMed ID: 7903175
    [Abstract] [Full Text] [Related]

  • 4. A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells.
    Bacus SS, Huberman E, Chin D, Kiguchi K, Simpson S, Lippman M, Lupu R.
    Cell Growth Differ; 1992 Jul; 3(7):401-11. PubMed ID: 1358180
    [Abstract] [Full Text] [Related]

  • 5. The role of erbB-2 and its ligands in growth control of malignant breast epithelium.
    Lupu R, Dickson RB, Lippman ME.
    Princess Takamatsu Symp; 1991 Jul; 22():49-60. PubMed ID: 1688228
    [Abstract] [Full Text] [Related]

  • 6. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis.
    Yen L, You XL, Al Moustafa AE, Batist G, Hynes NE, Mader S, Meloche S, Alaoui-Jamali MA.
    Oncogene; 2000 Jul 20; 19(31):3460-9. PubMed ID: 10918604
    [Abstract] [Full Text] [Related]

  • 7. Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
    Xu FJ, Stack S, Boyer C, O'Briant K, Whitaker R, Mills GB, Yu YH, Bast RC.
    Clin Cancer Res; 1997 Sep 20; 3(9):1629-34. PubMed ID: 9815853
    [Abstract] [Full Text] [Related]

  • 8. Heregulin induces increase in sensitivity of an erbB-2-overexpressing breast cancer cell type to lysis by lymphokine-activated killer cells.
    Cardillo M, Yankelevich B, Mazumder A, Lupu R.
    Cancer Immunol Immunother; 1996 Sep 20; 43(1):19-25. PubMed ID: 8917631
    [Abstract] [Full Text] [Related]

  • 9. C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines.
    Grothey A, Hashizume R, Ji H, Tubb BE, Patrick CW, Yu D, Mooney EE, McCrea PD.
    Oncogene; 2000 Oct 05; 19(42):4864-75. PubMed ID: 11039904
    [Abstract] [Full Text] [Related]

  • 10. Involvement of heregulin-beta2 in the acquisition of the hormone-independent phenotype of breast cancer cells.
    Tang CK, Perez C, Grunt T, Waibel C, Cho C, Lupu R.
    Cancer Res; 1996 Jul 15; 56(14):3350-8. PubMed ID: 8764133
    [Abstract] [Full Text] [Related]

  • 11. TGFβ and EGF signaling orchestrates the AP-1- and p63 transcriptional regulation of breast cancer invasiveness.
    Sundqvist A, Vasilaki E, Voytyuk O, Bai Y, Morikawa M, Moustakas A, Miyazono K, Heldin CH, Ten Dijke P, van Dam H.
    Oncogene; 2020 May 15; 39(22):4436-4449. PubMed ID: 32350443
    [Abstract] [Full Text] [Related]

  • 12. Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance.
    Lupu R, Cardillo M, Harris L, Hijazi M, Rosenberg K.
    Semin Cancer Biol; 1995 Jun 15; 6(3):135-45. PubMed ID: 7495981
    [Abstract] [Full Text] [Related]

  • 13. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG, Ethier SP.
    Cell Growth Differ; 1996 May 15; 7(5):551-61. PubMed ID: 8732665
    [Abstract] [Full Text] [Related]

  • 14. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer.
    Datta D, Flaxenburg JA, Laxmanan S, Geehan C, Grimm M, Waaga-Gasser AM, Briscoe DM, Pal S.
    Cancer Res; 2006 Oct 01; 66(19):9509-18. PubMed ID: 17018607
    [Abstract] [Full Text] [Related]

  • 15. Transactivation of ErbB-2 induced by tumor necrosis factor alpha promotes NF-kappaB activation and breast cancer cell proliferation.
    Rivas MA, Tkach M, Beguelin W, Proietti CJ, Rosemblit C, Charreau EH, Elizalde PV, Schillaci R.
    Breast Cancer Res Treat; 2010 Jul 01; 122(1):111-24. PubMed ID: 19760502
    [Abstract] [Full Text] [Related]

  • 16. Tyrosine kinase receptor--nuclear protooncogene interactions in breast cancer.
    Dickson RB, Salomon DS, Lippman ME.
    Cancer Treat Res; 1992 Jul 01; 61():249-73. PubMed ID: 1360236
    [Abstract] [Full Text] [Related]

  • 17. Regulation of estrogen receptor concentration and activity by an erbB/HER ligand in breast carcinoma cell lines.
    Saceda M, Grunt TW, Colomer R, Lippman ME, Lupu R, Martin MB.
    Endocrinology; 1996 Oct 01; 137(10):4322-30. PubMed ID: 8828492
    [Abstract] [Full Text] [Related]

  • 18. Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer.
    Iglehart JD, Kerns BJ, Huper G, Marks JR.
    Breast Cancer Res Treat; 1995 Jun 01; 34(3):253-63. PubMed ID: 7579490
    [Abstract] [Full Text] [Related]

  • 19. ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis.
    Worzfeld T, Swiercz JM, Looso M, Straub BK, Sivaraj KK, Offermanns S.
    J Clin Invest; 2012 Apr 01; 122(4):1296-305. PubMed ID: 22378040
    [Abstract] [Full Text] [Related]

  • 20. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG, Dilts CA, Dziubinski ML, Pierce LJ, Ethier SP.
    Mol Carcinog; 1996 Mar 01; 15(3):227-38. PubMed ID: 8597535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.